Risks of routine iron and folic acid supplementation for young children

S Pasricha1, A Shet, H P S Sachdev

  • 1St Johns Research Institute, St Johns National Academy of Health Sciences, Bangalore, India.

Indian Pediatrics
|November 6, 2009
PubMed

Insights

Routine iron-folic acid (IFA) supplementation for young children in India may increase malaria risk. Recommendations are being revised for malaria-endemic areas, balancing anemia treatment with infection prevention.

Area of Science:

  • Pediatric Nutrition
  • Public Health Policy
  • Infectious Disease Epidemiology

Background:

  • Iron-folic acid (IFA) supplementation is recommended for nearly 70% of anemic young children in India.
  • A potential risk associated with routine IFA supplementation is an increased incidence of infectious diseases, particularly malaria.

Purpose of the Study:

  • To review the evidence on iron-folic acid (IFA) supplementation in children under 5.
  • To inform updated recommendations for IFA supplementation policies in India, considering malaria endemicity.

Main Methods:

  • Conducted an extensive literature search across PubMed, WHO, and Indian Government databases.
  • Focused on studies concerning IFA supplementation in children under 5 years of age.

Main Results:

  • Previous reviews indicated potential adverse effects of IFA in malaria-endemic areas.
  • A recent trial in Tanzania showed increased malaria-related mortality with IFA, while a Nepal study found no adverse effects in a non-malarious region.
  • These findings led the World Health Organization to revise IFA supplementation guidelines for malaria-endemic regions.

Conclusions:

  • India exhibits varied malaria endemicity across regions.
  • Routine IFA supplementation should continue in non-malarious areas without modification.
  • In malarious regions, IFA supplementation should be implemented cautiously, contingent upon effective malaria control and functioning primary healthcare infrastructure.
Abstract

Related Concept Videos

Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...